155 related articles for article (PubMed ID: 22966388)
1. Limitations of tissue microarrays compared with whole tissue sections in survival analysis.
Khouja MH; Baekelandt M; Sarab A; Nesland JM; Holm R
Oncol Lett; 2010 Sep; 1(5):827-831. PubMed ID: 22966388
[TBL] [Abstract][Full Text] [Related]
2. Tissue microarray is suitable for scientific biomarkers studies in endometrial cancer.
Visser NCM; van der Wurff AAM; Pijnenborg JMA; Massuger LFAG; Bulten J; Nagtegaal ID
Virchows Arch; 2018 Mar; 472(3):407-413. PubMed ID: 29426961
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarrays: one size does not fit all.
Eckel-Passow JE; Lohse CM; Sheinin Y; Crispen PL; Krco CJ; Kwon ED
Diagn Pathol; 2010 Jul; 5():48. PubMed ID: 20609235
[TBL] [Abstract][Full Text] [Related]
4. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours.
Cunha KS; Caruso AC; Gonçalves AS; Bernardo VG; Pires AR; da Fonseca EC; de Faria PA; da Silva LE; Geller M; de Moura-Neto RS; Lopes VS
J Clin Pathol; 2009 Jul; 62(7):629-33. PubMed ID: 19318344
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of high-throughput small-core (0.6-mm) and large-core (2-mm) thyroid tissue microarray: is larger better?
Jones S; Prasad ML
Arch Pathol Lab Med; 2012 Feb; 136(2):199-203. PubMed ID: 22288969
[TBL] [Abstract][Full Text] [Related]
6. Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Andersen J; Overgaard J
Acta Oncol; 2008; 47(4):591-9. PubMed ID: 18465327
[TBL] [Abstract][Full Text] [Related]
7. Influence of intra-tumoral heterogeneity on the evaluation of BCL2, E-cadherin, EGFR, EMMPRIN, and Ki-67 expression in tissue microarrays from breast cancer.
Tramm T; Kyndi M; Sørensen FB; Overgaard J; Alsner J
Acta Oncol; 2018 Jan; 57(1):102-106. PubMed ID: 29202620
[TBL] [Abstract][Full Text] [Related]
8. Tissue microarray sampling strategy for prostate cancer biomarker analysis.
Rubin MA; Dunn R; Strawderman M; Pienta KJ
Am J Surg Pathol; 2002 Mar; 26(3):312-9. PubMed ID: 11859202
[TBL] [Abstract][Full Text] [Related]
9. Validation of a low-cost modified technique for constructing tissue microarrays for canine mammary tumor analysis.
Silva FB; Leite Jda S; de Mello MF; Ferreira AM
Pathol Res Pract; 2016 Sep; 212(9):783-90. PubMed ID: 27461825
[TBL] [Abstract][Full Text] [Related]
10. Digital pathology for the validation of tissue microarrays in peripheral T-cell lymphomas.
Pedersen MB; Riber-Hansen R; Nielsen PS; Bendix K; Hamilton-Dutoit SJ; D'Amore F; Steiniche T
Appl Immunohistochem Mol Morphol; 2014 Sep; 22(8):577-84. PubMed ID: 24897068
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma.
Bhargava R; Lal P; Chen B
Diagn Mol Pathol; 2004 Dec; 13(4):213-6. PubMed ID: 15538111
[TBL] [Abstract][Full Text] [Related]
12. "Analysis of immunohistochemical expression of epidermal growth factor receptor in oral squamous cell carcinoma using tissue microarray technology and whole sections:" A comparative study.
Sajjanar M; Sajjan P; Puranik RS; Vanaki S; Jayanth V; Naik P
J Oral Maxillofac Pathol; 2020; 24(3):499-504. PubMed ID: 33967487
[TBL] [Abstract][Full Text] [Related]
13. High-throughput immunophenotyping of 43 ferret lymphomas using tissue microarray technology.
Hammer AS; Williams B; Dietz HH; Hamilton-Dutoit SJ
Vet Pathol; 2007 Mar; 44(2):196-203. PubMed ID: 17317796
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous programmed death-ligand 1 expression in gastric cancer: comparison of tissue microarrays and whole sections.
Ye M; Huang D; Zhang Q; Weng W; Tan C; Qin G; Jiang W; Sheng W; Wang L
Cancer Cell Int; 2020; 20():186. PubMed ID: 32489322
[TBL] [Abstract][Full Text] [Related]
15. Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study.
Oshiro H; Czerniak BA; Sakamaki K; Tsuta K; Bondaruk J; Keyhani A; Dinney CP; Nagai T; Kamat AM
Medicine (Baltimore); 2016 Aug; 95(31):e4500. PubMed ID: 27495099
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ProExC as a prognostic marker in oropharyngeal squamous cell carcinomas.
Mills AM; Beck AH; Pourmand N; Le QT; Kong CS
Am J Surg Pathol; 2012 Aug; 36(8):1158-64. PubMed ID: 22790856
[TBL] [Abstract][Full Text] [Related]
17. Radiographic determination of tissue thickness in paraffin blocks: application to the construction of tissue microarrays.
Kong X; Zhao Y; Ksionsk M; Zhou M; Walden P; Bosland M; Pei Z; Lee P; Melamed J
Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):108-12. PubMed ID: 17536317
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expressions of Ki-67, cyclin D1, beta-catenin, cyclooxygenase-2, and epidermal growth factor receptor in human colorectal adenoma: a validation study of tissue microarrays.
Su Y; Shrubsole MJ; Ness RM; Cai Q; Kataoka N; Washington K; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1719-26. PubMed ID: 16985035
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods.
Khoury T; Zirpoli G; Cohen SM; Geradts J; Omilian A; Davis W; Bshara W; Miller R; Mathews MM; Troester M; Palmer JR; Ambrosone CB
Am J Clin Pathol; 2017 Aug; 148(2):108-118. PubMed ID: 28898983
[TBL] [Abstract][Full Text] [Related]
20. Breast Biomarkers-Comparison on Whole Section and Tissue Microarray Section.
Chavan SS; Ravindra S; Prasad M
J Clin Diagn Res; 2017 Mar; 11(3):EC40-EC44. PubMed ID: 28511394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
